(1)
Chimalakonda, A.; Burke, J.; Cheng, L.; Catlett, I.; Patel, A.; Shen, J.; Girgis, I.; Banerjee, S.; Throup, J. Selective Inhibition of Tyrosine Kinase 2 With Deucravacitinib (BMS-986165) Compared With Janus Kinase 1−3 Inhibitors. J of Skin 2020, 4, s108.